Travere Therapeutics (NASDAQ:TVTX) climbed ~27% in the premarket on Wednesday after the company said that the FDA has informed it that an advisory committee meeting will not be necessary to review a ...
Biohaven (NYSE:BHVN) shares spiked in the premarket on Friday after the FDA revoked an advisory committee meeting scheduled in connection with its marketing application for lead drug troriluzole.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results